[1]
Dajsakdipon, T. et al. 2021. Real World Experience of Long Term Treatment Outcome in Hormone Receptor-positive Metastatic Breast Cancer with or without Everolimus and Exemestane after Prior Aromatase Inhibitor. Asian Pacific Journal of Cancer Care. 6, 2 (May 2021), 149–158. DOI:https://doi.org/10.31557/apjcc.2021.6.2.149-158.